AVE 33.3% 0.2¢ avecho biotechnology limited

Ann: Phosphagenics Rights Issue - Appendix 3B, page-42

  1. 897 Posts.
    lightbulb Created with Sketch. 44
    This is a financial decision for the individual S/H MA. From my perspective I can't really afford it but I don't see I have a choice to avoid my current holding being diluted.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.